NRC Health reports developments in healthcare experience improvement solutions for hospitals and health systems. Its updates cover products and services such as Patient Experience, Market Insights, Reputation, Leader Rounding, and The Governance Institute, a service that provides governance research, education, assessments, conferences, and advisory resources for not-for-profit hospital and health system boards.
Company news commonly includes quarterly operating results, Total Recurring Contract Value disclosures tied to renewable contracts, cash flow and adjusted performance measures, health system partnership expansions, online reputation and consumer insight initiatives, industry recognition, governance publications, and capital allocation actions such as share repurchase authorizations.
NRC Health released its 2023 Experience Perspective, highlighting insights from over 300 healthcare leaders and 300,000 consumer surveys. The report emphasizes the importance of Human Understanding in improving patient experience and loyalty. Key findings include that only 38% of patients felt uniquely treated, despite this being crucial for Net Promoter Score. The report identifies fundamental strategies for enhancing healthcare experiences and underscores the significance of patient perspectives on quality. It also addresses the need for equity in care and outlines trends for healthcare leaders to consider in order to strengthen organizational performance.
National Research Corporation (NRC) reported 7% year-over-year revenue growth for 2022, driven by its Human Understanding Program. The company added notable clients like St. Bernards Healthcare and received the Best in KLAS 2023 Award for Patient Experience Improvement. However, revenue growth was partially offset by the phase-out of Canadian operations. For 2022, NRC allocated $12.2 million for innovation, $21.0 million for dividends, and $27.6 million for share repurchases. Diluted earnings per share fell to $1.27 for the year from $1.46 in 2021, highlighting financial challenges amidst strategic investments.
Summary not available.
National Research Corporation (NASDAQ:NRC) has announced a quarterly cash dividend of $0.12 per share, payable on April 14, 2023. Shareholders of record as of March 31, 2023 will be eligible for this payment. With over 40 years in the healthcare sector, NRC Health focuses on enhancing customer experiences in healthcare organizations. Their approach emphasizes empathy, proprietary methods, and skilled associates to elevate patient and staff satisfaction while fostering loyalty.
National Research Corporation (NASDAQ:NRC) announced an online web simulcast of its 2022 fourth quarter earnings conference call, scheduled for February 15, 2023, at 11:00 a.m. Eastern Time. Results will be released after market close on February 14, 2023. A 30-day online replay will be available post-broadcast. The webcast can be accessed at this link. NRC Health, with over 40 years of experience, focuses on enhancing healthcare organizations' understanding of their customers to improve experiences and foster trust.
NRC Health (NASDAQ:NRC) has declared a quarterly cash dividend of $0.12 per share, payable on January 13, 2023. Shareholders of record by December 30, 2022 will receive this payment. NRC Health focuses on enhancing patient experiences and relationships in healthcare, utilizing proprietary methods and a holistic approach.
NRC Health reported its third-quarter 2022 results, revealing revenue of $37.7 million, slightly down from $37.8 million in Q3 2021. The company’s net income declined to $8.3 million from $9.7 million year-over-year, leading to a decrease in diluted earnings per share, which fell to $0.33 from $0.38. Despite revenue growth from core offerings, the overall revenue was flat due to the phasing out of Canadian operations and a decline in non-core offerings. Increased operating expenses were attributed to investments in innovation and marketing. Dividends paid amounted to $5.9 million.
NRC Health's recent study reveals a significant disparity in trust levels between local healthcare providers and government entities during the COVID-19 pandemic. The research indicates that patients' language preferences notably influence their trust in healthcare providers, with English speakers 29% more likely to express strong trust. Additionally, trust in local healthcare systems rose from 20.7% to 35.8% from April 2020 to August 2022, while federal trust waned. Notably, trust levels are politically mixed across U.S. counties, challenging the narrative that political affiliation heavily influences provider trust.
On October 19, 2022, National Research Corporation (NASDAQ: NRC) announced an online web simulcast for its third quarter earnings conference call, scheduled for November 2, 2022, at 11:00 a.m. ET. The earnings results will be released after market close on November 1, 2022. A live audio webcast will be accessible via their website, with a replay available for 30 days after the event. NRC has a longstanding commitment to enhancing healthcare experiences through its proprietary methods and holistic approach.
NRC Health, a leader in personalized healthcare solutions, has announced its sponsorship of the Creative Learning Event Series organized by the Society for Participatory Medicine (SPM). This year-long initiative aims to enhance patient-provider relationships and promote equity in healthcare. The first event will be held on October 20, 2022, in Boston, focusing on access to care in underserved communities. NRC Health's support aligns with its mission of achieving Human Understanding, emphasizing collaboration among patients and healthcare professionals.